Related Experiment Video
Updated: Feb 14, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
A Clinical Prediction Model for Bacterial Coinfection in Children with Respiratory Syncytial Virus Infection: A
Di Lian1, Jianxing Wei1, Dong Wang1
1Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China.
Insights
This study developed a model using neutrophil-to-lymphocyte ratio, C-reactive protein, and serum amyloid A to accurately identify bacterial coinfection in children with respiratory syncytial virus (RSV) infections, aiding antibiotic stewardship.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Microbiology
- Biomarker Discovery
Background:
- Respiratory syncytial virus (RSV) is a major cause of pediatric lower respiratory tract infections.
- Bacterial coinfection in RSV cases complicates diagnosis and contributes to antibiotic overuse.
- Accurate identification of bacterial coinfection is crucial for appropriate treatment.
Purpose of the Study:
- To develop and validate a clinical prediction model for early identification of bacterial coinfection in children with RSV.
- To utilize common laboratory biomarkers for improved diagnostic accuracy.
- To support targeted antibiotic stewardship in pediatric RSV cases.
Main Methods:
- Retrospective cohort study of 518 hospitalized children with RSV infection.
- Development and validation of a prediction model using LASSO and multivariable logistic regression.
- Biomarkers including neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), and serum amyloid A (SAA) were analyzed.
Main Results:
- The prediction model integrated NLR, CRP, and SAA.
- The model demonstrated strong discrimination with an AUC of 0.832 in the training set and 0.811 in the test set.
- The model showed good calibration and clinical utility, with a developed nomogram for practical application.
Conclusions:
- A reliable model integrating NLR, CRP, and SAA was established for early bacterial coinfection detection in RSV-infected children.
- This tool can guide targeted antibiotic stewardship, potentially improving clinical outcomes.
- The findings support the use of this model in clinical practice for better management of pediatric RSV cases.
Abstract:
Objectives: Respiratory syncytial virus (RSV) is a leading cause of hospitalization for acute lower respiratory tract infections (ALRIs) in children, with bacterial coinfection complicating diagnosis and often driving antibiotic overuse. This study aimed to develop and validate a clinical prediction model using common laboratory biomarkers to enable early, accurate identification of clinically significant bacterial coinfection in children with RSV infection. Methods: A single-center, retrospective cohort study was conducted at Fujian Children's Hospital, enrolling 518 hospitalized children with RSV infection, which was confirmed via targeted next-generation sequencing (tNGS). Patients were randomly divided into a training set (n = 363) and a test set (n = 155) at a 7:3 ratio. The primary outcome, bacterial coinfection, was defined by a composite reference standard integrating etiological evidence from tNGS with clinical, inflammatory, and imaging data, and adjudicated by a blinded expert panel. LASSO regression identified independent predictors, followed by multivariable logistic regression modeling. Model performance was assessed via discrimination (AUC), calibration (Hosmer-Lemeshow test), and clinical utility (Decision Curve Analysis) in both sets. Results: Neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), and serum amyloid A (SAA) were selected as predictors. The model achieved an AUC of 0.832 (95% CI: 0.788-0.875) in the training set and 0.811 (95% CI: 0.737-0.885) in the test set, with well-calibrated predictions (p > 0.05). Decision curve analysis demonstrated net clinical benefit across 10-80% threshold probabilities. A nomogram was developed for practical application. Conclusions: This study established a model integrating NLR, CRP, and SAA. It offers a reliable tool for the early detection of bacterial coinfection in RSV-infected children, enabling targeted antibiotic stewardship and improving clinical outcomes.
Related Concept Videos
Reliability and Validity
Endocarditis II: Clinical Features of Infective Endocarditis
In Vitro Drug Release Testing: Overview, Development and Validation
What are Viruses?
Predicting Molecular Geometry
Aneurysm II: Clinical Manifestations and Diagnostic Studies

